ABSTRACT
PURPOSE: Our objective was to develop a tool promoting early detection of COVID-19 cases by focusing epidemiological investigations and PCR examinations during a period of limited testing capabilities. METHODS: We developed an algorithm for analyzing medical records recorded by healthcare providers in the Israeli Defense Forces. The algorithm utilized textual analysis to detect patients presenting with suspicious symptoms and was tested among 92 randomly selected units. Detection of a potential cluster of patients in a unit prompted a focused epidemiological investigation aided by data provided by the algorithm. RESULTS: During a month of follow up, the algorithm has flagged 17 of the units for investigation. The subsequent epidemiological investigations led to the testing of 78 persons and the detection of eight cases in four clusters that were previously gone unnoticed. The resulting positive test rate of 10.25% was five time higher than the IDF average at the time of the study. No cases of COVID-19 in the examined units were missed by the algorithm. CONCLUSIONS: This study depicts the successful development and large scale deployment of a textual analysis based algorithm for early detection of COVID-19 cases, demonstrating the potential of natural language processing of medical text as a tool for promoting public health.
Subject(s)
COVID-19 , Algorithms , COVID-19/diagnosis , COVID-19/epidemiology , Disease Outbreaks , Electronic Health Records , Humans , Natural Language ProcessingSubject(s)
Cardiology , Coronary Artery Disease , Preventive Medicine/education , Cardiac Rehabilitation/methods , Cardiology/education , Cardiology/methods , Cardiology/trends , Coronary Artery Disease/diagnosis , Coronary Artery Disease/prevention & control , Coronary Artery Disease/therapy , Education , Europe , Humans , Needs Assessment , Preventive Health Services/methods , Preventive Health Services/trendsABSTRACT
BACKGROUND: The COVID-19 outbreak required prompt action by health authorities around the world in response to a novel threat. With enormous amounts of information originating in sources with uncertain degree of validation and accuracy, it is essential to provide executive-level decision-makers with the most actionable, pertinent, and updated data analysis to enable them to adapt their strategy swiftly and competently. OBJECTIVE: We report here the origination of a COVID-19 dedicated response in the Israel Defense Forces with the assembly of an operational Data Center for the Campaign against Coronavirus. METHODS: Spearheaded by directors with clinical, operational, and data analytics orientation, a multidisciplinary team utilized existing and newly developed platforms to collect and analyze large amounts of information on an individual level in the context of SARS-CoV-2 contraction and infection. RESULTS: Nearly 300,000 responses to daily questionnaires were recorded and were merged with other data sets to form a unified data lake. By using basic as well as advanced analytic tools ranging from simple aggregation and display of trends to data science application, we provided commanders and clinicians with access to trusted, accurate, and personalized information and tools that were designed to foster operational changes and mitigate the propagation of the pandemic. The developed tools aided in the in the identification of high-risk individuals for severe disease and resulted in a 30% decline in their attendance to their units. Moreover, the queue for laboratory examination for COVID-19 was optimized using a predictive model and resulted in a high true-positive rate of 20%, which is more than twice as high as the baseline rate (2.28%, 95% CI 1.63%-3.19%). CONCLUSIONS: In times of ambiguity and uncertainty, along with an unprecedented flux of information, health organizations may find multidisciplinary teams working to provide intelligence from diverse and rich data a key factor in providing executives relevant and actionable support for decision-making.
Subject(s)
COVID-19 , Pandemics , Artificial Intelligence , Decision Making , Humans , SARS-CoV-2ABSTRACT
BACKGROUND: Telemedicine has become an integral part of health care delivery in recent years. One of the leading applications for this use is WhatsApp - a free smartphone application that allows instant messaging with pictures and videos. This study analyzed the emerging role of WhatsApp on reducing the need for referrals to medical specialists and to compare the views of physicians regarding WhatsApp consultations. METHODS: A cross-sectional study based on an anonymous web-survey was conducted among PCPs and medical specialists working in the Israel Defense Forces Medical-Corps during September and October, 2019. RESULTS: Of 201 participants, 153 were PCPs and 48 were medical specialists. 86.9 % of PCPs and 86.5 % of specialists used WhatsApp every day in professional settings. Added workload, potential breaching of patient confidentiality and lack of full documentation of consultations were the main concerns among physicians using the application. 60.7 % of PCPs and 95.7 % of specialists stated that these consultations have reduced the need for in-person appointments at least once a week. CONCLUSIONS: In times of COVID-19 that require social distancing, WhatsApp provides a simple, readily available platform for consultations between healthcare providers, even to the extent of rendering some in-person appointments unnecessary. Healthcare organizations should address the matters troubling healthcare providers, mainly patient confidentiality and lack of documentation in patients' medical records, while providing adequate compensation for those providing the service during and after work hours.
Subject(s)
COVID-19 , Mobile Applications , Physicians/statistics & numerical data , Telemedicine/methods , Adult , Cross-Sectional Studies , Delivery of Health Care/methods , Female , Humans , Israel , Male , Middle Aged , Referral and Consultation/statistics & numerical data , Smartphone , Surveys and QuestionnairesSubject(s)
COVID-19 , Internship and Residency , Physicians , Clinical Competence , Humans , SARS-CoV-2 , Surveys and QuestionnairesSubject(s)
Atherosclerosis/epidemiology , Ethnicity/statistics & numerical data , Internet/statistics & numerical data , Black or African American/statistics & numerical data , Age Factors , Betacoronavirus , COVID-19 , Coronary Disease/epidemiology , Coronavirus Infections , Delivery of Health Care , Educational Status , Employment , Female , Geography , Healthcare Disparities , Hispanic or Latino/statistics & numerical data , Humans , Internet Access/statistics & numerical data , Logistic Models , Male , Myocardial Infarction/epidemiology , Pandemics , Pneumonia, Viral , SARS-CoV-2 , Sex Factors , Stroke/epidemiology , Telemedicine , United States/epidemiology , White People/statistics & numerical dataABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has consumed our healthcare system, with immediate resource focus on the management of high numbers of critically ill patients. Those that fare poorly with COVID-19 infection more commonly have cardiovascular disease (CVD), hypertension and diabetes. There are also several other conditions that raise concern for the welfare of patients with and at high risk for CVD during this pandemic. Traditional ambulatory care is disrupted and many patients are delaying or deferring necessary care, including preventive care. New impediments to medication access and adherence have arisen. Social distancing measures can increase social isolation and alter physical activity and nutrition patterns. Virtually all facility based cardiac rehabilitation programs have temporarily closed. If not promptly addressed, these changes may result in delayed waves of vulnerable patients presenting for urgent and preventable CVD events. Here, we provide several recommendations to mitigate the adverse effects of these disruptions in outpatient care. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers should be continued in patients already taking these medications. Where possible, it is strongly preferred to continue visits via telehealth, and patients should be counselled about promptly reporting new symptoms. Barriers to medication access should be reviewed with patients at every contact, with implementation of strategies to ensure ongoing provision of medications. Team-based care should be leveraged to enhance the continuity of care and adherence to lifestyle recommendations. Patient encounters should include discussion of safe physical activity options and access to healthy food choices. Implementation of adaptive strategies for cardiac rehabilitation is recommended, including home based cardiac rehab, to ensure continuity of this essential service. While the practical implementation of these strategies will vary by local situation, there are a broad range of strategies available to ensure ongoing continuity of care and health preservation for those at higher risk of CVD during the COVID-19 pandemic.